Search Results
The product title you are looking for is no longer available. Other similar products that may interest you are listed below:
|
Results for 'Bukwang Pharmaceutical Company Limited -Company Report' |
|
|
| Title | Publication Date | Price | Relevance |
|---|---|---|---|
| Bukwang Pharmaceutical Company Limited-Therapeutic Competitors Report | Mar 2011 | £220 | 100% |
| Hepatitis B Global Clinical Trials Review H2, 2011 |
Oct 2011 | £630 | 75% |
| Hepatitis C - Pipeline Review H2 2011 |
Sep 2011 | £315 | 61% |
| Hepatitis - Pipeline Review H2 2011 |
Sep 2011 | £315 | 61% |
| South Korea Pharmaceuticals and Healthcare Report Q2 2009 | May 2009 | £330 | 61% |
| Biopharmaceuticals A Global Market Overview |
Apr 2010 | £2,960 | 60% |
| South Korea Pharmaceuticals and Healthcare Report Q3 2011 |
May 2011 | £330 | 60% |
| South Korea Pharmaceuticals and Healthcare Report Q4 2011 |
Aug 2011 | £330 | 59% |
- Results 1 - 8 of 8
-
-
- 1
-
-
